<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01353196</url>
  </required_header>
  <id_info>
    <org_study_id>CARA-024-10S</org_study_id>
    <nct_id>NCT01353196</nct_id>
  </id_info>
  <brief_title>Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates</brief_title>
  <acronym>ACCOF</acronym>
  <official_title>Asymptomatic Carotid Stenosis: Cognitive Function and Plaque Correlates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Carotid artery plaques are known to cause stroke. Cognitive impairment is an insidious but
      poorly understood problem in patients with carotid plaques. Cognitive function describes how
      people perform mental processes such as thinking, learning and problem solving. Asymptomatic
      carotid plaques may affect 1 million Veterans who may be at risk for cognitive impairment. In
      this study, the investigators will uncover the extent of cognitive impairment in Veterans
      with carotid stenosis who are currently labeled &quot;asymptomatic&quot;. Programs to prevent or
      mitigate cognitive impairment will depend on identifying the mechanisms by which this occurs.
      The investigators will use sophisticated 3D imaging techniques developed by the group to
      measure the structure and composition of plaques, number of particles breaking off from them,
      blood levels of chemicals that could disrupt them, and blood flow restriction to the brain
      from them. This will help identify patients at risk for cognitive impairment who may benefit
      from preventative measures and improve selection of patients to decrease unnecessary surgical
      procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carotid artery stenosis is a well-known cause of atheroembolic stroke. Stroke prevention in
      these patients has been the focus of intense investigation. Cognitive impairment is a more
      insidious but poorly understood outcome in patients with &quot;asymptomatic&quot; carotid stenosis who
      have not suffered a stroke. Cognitive function describes how a person produces and controls
      mental processes such as thinking, learning, and problem solving. It is an important outcome
      measure that affects patient well-being and their ability to live independent productive
      lies. It is well-known that cognitive impairment coexists in patients with stroke from
      carotid stenosis. However, isolated cognitive deficits in patients with asymptomatic carotid
      stenosis have not been looked for, and have therefore not been reported in any detail.
      Asymptomatic carotid stenosis affects 2-12% of people. With 23.4 million Veterans in the
      country, at least 1 million (4.3%) have asymptomatic carotid stenosis and are at risk for
      cognitive impairment. A subset analysis of the Cardiovascular Health Study found cognitive
      decline in 34% of 32 patients with asymptomatic carotid stenosis. In this proposal, the
      investigators will define the extent of initial and progressive cognitive impairment in
      Veterans with carotid stenosis who are currently labeled as &quot;asymptomatic&quot; in the absence of
      a focal neurologic deficit (stroke, transient ischemic attack). Programs to prevent,
      postpone, or mitigate cognitive impairment in patients with carotid stenosis will depend on
      the identification of mediators for cognitive impairment. Microembolic brain injury and
      cerebral hypoperfusion have been associated with cognitive impairment in elderly individuals.

      Therefore plaque architecture, plaque composition, microembolic counts, serum inflammatory
      markers, and cerebral hypoperfusion are likely mediators of impaired cognition in patients
      with asymptomatic carotid stenosis. As part of this proposal, the investigators will identify
      the biological mechanisms by which carotid stenosis could result in cognitive impairment.

      The goal of this proposal is to perform a systematic, adequately powered study to measure the
      magnitude of cognitive impairment in asymptomatic carotid stenosis, its impact on quality of
      life, and its potential pathophysiological mechanisms. Information from this study will
      define an unsuspected morbidity of carotid stenosis and identify subsets of patients at risk
      for cognitive impairment. It will form the foundation for future studies on prevention,
      pre-emptive treatment, or rehabilitation of patients with carotid stenosis. It will also
      improve the selection of patients with carotid stenosis to decrease unnecessary
      revascularization procedures.

      Specific Aim 1 will assess if patients with asymptomatic carotid stenosis differ in cognitive
      function compared to age-matched controls without carotid stenosis but with similar vascular
      risk profiles. The investigators hypothesize that in patients with asymptomatic carotid
      stenosis 50% who survive stroke free for 2 years; the change in overall and domain-specific
      cognitive function will be significantly different compared to those without stenosis. The
      study will recruit 284 subjects and will detect a clinically significant difference in
      cognitive score with 90% power. The investigators will use a novel battery of cognitive tests
      specifically developed to address the unique issues relating to carotid stenosis.

      Specific Aim 2 will define plaque-morphometric, biologic, and hemodynamic characteristics
      that correlate with cognitive impairment in patients with asymptomatic carotid stenosis. The
      investigators hypothesize that carotid plaque architecture, plaque composition, microembolic
      counts, serum pro-inflammatory markers, and cerebral hypoperfusion could each mediate
      cognitive decline over a 2-year follow-up period. The investigators will implement a novel
      clinical 3D B-mode ultrasound imaging technique developed to obtain reliable serial plaque
      measurements.

      Specific Aim 3 will measure the impact of cognitive impairment on quality of life. The
      investigators hypothesize that at 2 years, regardless of plaque features, cognitive
      impairment will correlate with a reduction in health-related quality of life measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2011</start_date>
  <completion_date type="Actual">February 28, 2018</completion_date>
  <primary_completion_date type="Actual">February 28, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Cognitive Score</measure>
    <time_frame>2 years</time_frame>
    <description>composite of multiple cognitive function test scores scores are reported as mean +/- standard deviation 0 = worst 100 = best</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">170</enrollment>
  <condition>Cognitive Manifestations</condition>
  <arm_group>
    <arm_group_label>stenosis</arm_group_label>
    <description>carotid stenosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no stenosis</arm_group_label>
    <description>no stenosis</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples for inflammatory markers
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients eligible for the study will have asymptomatic &gt;=50% carotid stenosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asymptomatic 50% carotid stenosis or more

        Exclusion Criteria:

          -  previous stroke or transient ischemic attack (TIA)

          -  severe medical illness that would interfere with evaluation of outcomes or reduce the
             likelihood of a 2-year follow-up

          -  carotid occlusion

          -  patients scheduled for carotid revascularization procedures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brajesh K Lal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Lal BK, Dux MC, Sikdar S, Goldstein C, Khan AA, Yokemick J, Zhao L. Asymptomatic carotid stenosis is associated with cognitive impairment. J Vasc Surg. 2017 Oct;66(4):1083-1092. doi: 10.1016/j.jvs.2017.04.038. Epub 2017 Jul 14.</citation>
    <PMID>28712815</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 11, 2011</study_first_submitted>
  <study_first_submitted_qc>May 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2011</study_first_posted>
  <results_first_submitted>February 15, 2019</results_first_submitted>
  <results_first_submitted_qc>May 21, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 24, 2019</results_first_posted>
  <last_update_submitted>May 21, 2019</last_update_submitted>
  <last_update_submitted_qc>May 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carotid</keyword>
  <keyword>atherosclerosis</keyword>
  <keyword>cognitive function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Neurobehavioral Manifestations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 21, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT01353196/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Stenosis</title>
          <description>participants with carotid stenosis</description>
        </group>
        <group group_id="P2">
          <title>no Stenosis</title>
          <description>participants with no carotid artery stenosis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Stenosis</title>
          <description>carotid stenosis</description>
        </group>
        <group group_id="B2">
          <title>no Stenosis</title>
          <description>no carotid artery stenosis</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="100"/>
            <count group_id="B2" value="70"/>
            <count group_id="B3" value="170"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50" spread="10"/>
                    <measurement group_id="B2" value="50" spread="10"/>
                    <measurement group_id="B3" value="50" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Composite cognitive function</title>
          <description>0 = worst 100 = best</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.5" spread="6.0"/>
                    <measurement group_id="B2" value="47.9" spread="5.0"/>
                    <measurement group_id="B3" value="46.0" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite Cognitive Score</title>
        <description>composite of multiple cognitive function test scores scores are reported as mean +/- standard deviation 0 = worst 100 = best</description>
        <time_frame>2 years</time_frame>
        <population>Participants that did not complete the study or missing key data elements were excluded from the overall analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Stenosis</title>
            <description>carotid stenosis</description>
          </group>
          <group group_id="O2">
            <title>no Stenosis</title>
            <description>no carotid artery stenosis</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Cognitive Score</title>
          <description>composite of multiple cognitive function test scores scores are reported as mean +/- standard deviation 0 = worst 100 = best</description>
          <population>Participants that did not complete the study or missing key data elements were excluded from the overall analysis</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
                <count group_id="O2" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" spread="6.0"/>
                    <measurement group_id="O2" value="47.9" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Stenosis</title>
          <description>carotid stenosis</description>
        </group>
        <group group_id="E2">
          <title>no Stenosis</title>
          <description>no carotid artery stenosis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="70"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="70"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brajesh K. Lal, MD</name_or_title>
      <organization>VA Medical Center VA Maryland Health Care System, Baltimore, MD</organization>
      <phone>410-605-7000</phone>
      <email>blal@som.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

